Error: Could not add to watchlist. X

Northwest Biotherapeutics Inc

+ Watchlist
NBYA:GR
Frankfurt
10.20
EUR
0.14
1.35%
As of 05:57:19 ET on 08/03/2015.
Open
10.19
Day Range
10.19 - 10.22
Volume
160
Previous Close
10.06
52Wk Range
2.96 - 11.42
1 Yr Return
110.90%
Open
10.19
Day Range
10.19 - 10.22
Volume
160
Previous Close
10.06
52Wk Range
2.96 - 11.42
1 Yr Return
110.90%
YTD Return
126.35%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (m EUR)
784.037
Shares Outstanding (m)
76.889
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Northwest Biotherapeutics, Inc., a biotechnology company, discovers, develops, and commercializes immunotherapy products. The Company's products generate and enhance immune system responses to treat cancer. The DCVax product candidate platform creates cancer immunotherapies.
ADDRESS
4800 Montgomery Lane
Suite 800
Bethesda, MD 20814
United States
PHONE
1-240-497-9024
  • Linda F Powers
    Chairman/President/CEO
  • Marnix L Bosch
    Chief Technology Officer
  • Anthony E Maida
    Senior VP:Clinical Research
  • Alton L Boynton
    Chief Scientific Officer
  • Leslie J Goldman
    Senior VP:Business Dev/Investor Rels
Show More